Dr. Anil Sood, MD

• Gynecologic Oncology

• Obstetrics & Gynecology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of North Carolina At Chapel Hill

  Medical School, 2005

• Advancing Drug Development in Gynecologic Malignancies, 2019-05-24

• A novel platform for detection of CK+ and CK- CTCs, 2011-12-01

• LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response, 2018-01-31

• Biobehavioral Factors and Cancer Progression: Physiological Pathways and Mechanisms, 2011-10-21

• Metabolic Markers and Statistical Prediction of Serous Ovarian Cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging, 2017-04-17

• Assessment ofin vivosiRNA delivery in cancer mouse models, 2016-12-03

• MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis, 2016-10-19

• Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer, 2015-07-27

• Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer, 2015-05-23

• A miR-155/TP53 regulatory feedback loop involved in resistance to therapy in lung cancer and leukemia, 2016-11-30

• Differentiation Therapy for Hepatocellular Carcinoma: multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis, 2016-01-14

• Therapeutic Silencing of KRAS using Systemically Delivered siRNAs, 2014-10-03

• Metronomic docetaxel in PRINT®nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer, 2014-04-22

• Enhanced immunotherapy with LHRH-R targeted lytic peptide in ovarian cancer, 2020-09-17

• miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer, 2019-12-24

• Critical Questions in Ovarian Cancer Research and Treatment: Report of an AACR Special Conference, 2019-03-05

• Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: time to incorporate laparoscopic assessment into the standard of care, 2015-03-28

• Factors Associated with Response to Neoadjuvant Chemotherapy in Advanced Stage Ovarian Cancer, 2021-04-07

• Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors, 2011-07-30

• PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway, 2021-02-13

• Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer, 2016-02-23

• Differential platelet levels affect response to taxane-based therapy in ovarian cancer, 2014-12-03

• The role of long noncoding RNAs in cancer: the dark matter matters, 2017-10-17

• Role of Micro-RNA for Pain After Surgery: Narrative Review of Animal and Human Studies, 2021-10-01

• Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer, 2012-07-19

• Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma, 2015-07-31

• ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer, 2018-04-17

• Editorial: Cardio-Oncology: From Bench to Bedside, 2019-04-10

• Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer, 2017-12-13

• Beta blockers: A new role in chemotherapy, 2013-08-07

• Sleep Disturbance, Distress, and Quality of Life in Ovarian Cancer Patients during the First Year Post Diagnosis, 2013-06-24

• Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors, 2022-12-17

• YAP1 and TAZ Activates mTORC1 Pathway by Regulating Amino Acid Transporters in hepatocellular carcinoma, 2015-11-26

• Adrenergic stimulation of DUSP1 impairs chemotherapy response in ovarian cancer, 2015-11-18

• CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis, 2015-07-06

• Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors, 2017-01-26

• Tumour angiogenesis regulation by the miR-200 family, 2013-12-28

• Bone protection by inhibition of microRNA-182, 2018-10-05

• Performance of the MasSpec Pen for Rapid Diagnosis of Ovarian Cancer, 2019-02-15

• Targeting c-MYC in platinum-resistant ovarian cancer, 2015-07-30

• Shedding light on the dark cancer genomes: long non-coding RNAs as novel biomarkers and potential therapeutic targets for cancer, 2018-07-17

• Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer, 2022-02-23

• Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions, 2020-01-16

• Crosstalk between EphA2 and BRaf/CRaf is a Key Determinant of Response to Dasatinib, 2014-01-31

• Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas, 2021-04-19

• miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer, 2016-03-27

• Social integration, marital status, and ovarian cancer risk: A 20-year prospective cohort study, 2019-09-13

• TP53 loss creates therapeutic vulnerability in colorectal cancer, 2015-04-22

• Diurnal Cortisol and Survival in Epithelial Ovarian Cancer, 2015-01-20

• Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy, 2017-11-24

• A New Method for Stranded Whole Transcriptome RNA-seq, 2013-04-01

• SSRI use and clinical outcomes in epithelial ovarian cancer, 2016-04-21

• Contemporary use of Bevacizumab in ovarian cancer, 2012-11-29

• Depressive Symptoms and Cortisol Rhythmicity Predict Survival in Patients with Renal Cell Carcinoma: Role of Inflammatory Signaling, 2012-08-01

• Clinical Impact of Selective and Non-selective Beta Blockers on Survival in Ovarian Cancer Patients, 2015-08-24

• Endothelial cell malignancies: new insights from the laboratory and clinic, 2017-04-20

• Small RNA sequencing across diverse biofluids identifies optimal methods for exRNA isolation, 2019-04-04

• Hematogenous metastasis of ovarian cancer: Rethinking mode of spread, 2014-07-14

• Macrophages facilitate resistance to anti-VEGF therapy by altered VEGFR expression, 2017-08-29

• Long noncoding RNA ceruloplasmin promotes cancer growth by altering glycolysis, 2015-12-10

• Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells, 2023-01-03

• 2'f-OMe-phosphorodithioate modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity, 2014-03-12

• Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer, 2021-02-05

• Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy, 2015-07-22

• Human tumor microenvironment chip evaluates the consequences of platelet extravasation and combinatorial antitumor-antiplatelet therapy in ovarian cancer, 2021-07-21

• The Provocative Roles of Platelets in Liver Disease and Cancer, 2021-07-21

• Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with beta blockers, 2017-11-08

• Anti-tumor and Anti-angiogenic Effects of Aspirin-PC in Ovarian Cancer, 2016-09-16

• Novel markers for liquid biopsies in cancer management: Circulating platelets and extracellular vesicles, 2022-07-05

• A Modified 2 Tier Chemotherapy Response Score (CRS) and Other Histopathologic Features for Predicting Outcomes of Patients with Advanced Extrauterine High-Grade Serous Carcinoma after Neoadjuvant Chemotherapy, 2021-02-09

• Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation, 2022-06-10

• Antibody therapeutics for epithelial ovarian cancer, 2022-11-05

• Photothermal-Chemotherapy with Doxorubicin-Loaded Hollow Gold Nanospheres: A Platform for Near-Infrared Light-Trigged Drug Release, 2011-10-28

• Sustained adrenergic signaling leads to increased metastasis in ovarian cancerviaincreased PGE2 synthesis, 2015-08-10

• Rac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancer, 2015-01-16

• The rise of genomic profiling in ovarian cancer, 2017-06-23

• miR-205 acts as a tumor radiosensitizer by targeting ZEB1 and Ubc13, 2014-12-05

• Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation, 2018-02-02

• Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy, 2017-08-24

• Effects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma, 2019-10-03

• Nanotechnology: Future of Oncotherapy, 2015-07-15

• Phase II evaluation of Dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study, 2012-06-16

• MicroRNA deregulation in cancer cells and the tumor microenvironment, 2016-02-10

• ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy, 2016-08-08

• Calcium Dependent FAK/CREB/TNNC1 Signaling Mediates the Effect of Stromal MFAP5 on Ovarian Cancer Metastatic Potential, 2014-10-03

• Copy number deletion of RAD50 as predictive marker of BRCAness and PARP inhibitor response in BRCA wild type ovarian cancer, 2016-03-09

• Platelets and cancer: a casual or causal relationship: revisited, 2014-09-28

• Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions, 2014-03-05

• Platelets Increase the Expression of PD-L1 in Ovarian Cancer, 2022-05-19

• NO-dependent attenuation of TPA-induced immunoinflammatory skin changes in Balb/c mice by pindolol, heptaminol or ATRA, but not by verapamil, 2016-06-22

• PTENexpression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer, 2015-04-01

• Aspirin use and endometrial cancer risk and survival, 2017-11-11

• Phase II trial of Bevacizumab with Dose-dense Paclitaxel as First-Line Treatment in Patients with Advanced Ovarian Cancer, 2017-08-01

• Non-Cancer Life Stressors Contribute to Impaired Quality of Life in Ovarian Cancer Patients, 2013-10-03

• Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer, 2013-02-11

• Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies, 2013-08-02

• Platelets are not hyperreactive in patients with ovarian cancer, 2016-05-16

• Poor survival with wild-typeTP53ovarian cancer?, 2013-06-22

• Quaking Orchestrates a Post-Transcriptional Regulatory Network of Endothelial Cell Cycle Progression Critical to Angiogenesis and Metastasis, 2019-03-27

• Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches, 2014-12-30

• Differing clinical impact ofBRCA1andBRCA2mutations in serous ovarian cancer, 2013-02-05

• Erratum to: MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis, 2017-10-06

• Endothelial p130cas confers resistance to anti-angiogenesis therapy, 2022-01-25

• Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L, 2023-04-26

• GnRH-R targeted lytic peptide sensitizes BRCA wild-type ovarian cancer to PARP inhibition, 2019-03-29

• ExRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present Across Human Biofluids, 2019-04-04

• Ovarian cancer, 2016-08-25

• Unverifiable Accomplishments and Publications on Applications for Gynecologic Oncology Fellowships, 2013-12-03

• Blockade of the short Form of prolactin receptor induces FOXO3a/EIF-4EBP1-mediated cell death in uterine cancer, 2020-07-31

• Biological effects of platelet-derived growth factor receptor a blockade in uterine cancer, 2014-03-14

• Advances and Challenges of Liposome Assisted Drug Delivery, 2015-12-01

• Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression, 2019-07-25

• CD8+T cells inhibit metastasis and CXCL4 regulates its function, 2021-04-01

• BET inhibitors suppress ALDH activity by targetingALDH1A1super-enhancer in ovarian cancer, 2016-11-01

• RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site, 2021-11-02

• Dual metronomic chemotherapy with nab-paclitaxel and topotecan has potent anti-angiogenic activity in ovarian cancer, 2015-10-29

• MYC targeted long non-coding RNA DANCR promotes cancer in part by reducing p21 levels, 2017-11-27

• Race-associated molecular changes in gynecologic malignancies, 2022-02-17

• A comprehensive Pan-Cancer molecular study of gynecologic and breast cancers, 2018-04-02

• Complement component 3 (C3) is regulated by TWIST1 and mediates epithelial-mesenchymal transition (EMT), 2015-12-30

• Clinical Significance of Homologous Recombination Deficiency Score Testing in Endometrial Cancer, 2021-02-06

• CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance, 2021-08-17

• Clinically translatable quantitative molecular photoacoustic imaging with liposome-encapsulated ICG J-aggregates, 2021-09-13

• Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review, 2020-05-29

• Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer, 2018-06-11

• Immune cell profiling in cancer: molecular approaches to cell-specific identification, 2017-08-15

• Neuroendocrine influences on cancer progression, 2012-06-21

• Effective Photothermal Chemotherapy Using Doxorubicin-Loaded Gold Nanospheres That Target EphB4 Receptors in Tumors, 2012-08-03

• Gene body methylation of the lymphocyte-specific geneCARD11results in its overexpression and regulates cancer mTOR signaling, 2021-08-04

• Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience, 2016-04-27

• Platelet effects on ovarian cancer, 2014-04-23

• Mind-Body Practices in Cancer Care, 2015-05-05

• Carcinoma of the Bartholin's Gland: A Review of 33 cases, 2016-01-06

• EGFL6 Promotes Breast Cancer by Simultaneously Enhancing Cancer Cell Metastasis and Stimulating Tumor Angiogenesis, 2018-11-19

• Ubiquitous Release Of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells, 2016-10-14

• Predictors of survival trajectories among women with epithelial ovarian cancer, 2019-12-12

• Cortisol and Inflammatory Processes in Ovarian Cancer Patients Following Primary Treatment: Relationships with Depression, Fatigue, and Disability, 2012-08-05

• The association of work characteristics with ovarian cancer risk and mortality, 2017-03-18

• Oncolytic HSV therapy modulates vesicular trafficking inducing cisplatin sensitivity and anti-tumor immunity, 2020-10-21

• Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma, 2017-08-08

• Tumor core biopsies adequately represent immune microenvironment of high-grade serous carcinoma, 2019-11-26

• Preclinical and clinical development of siRNA-based therapeutics, 2015-02-07

• MiR-506 Suppresses Proliferation and Induces Senescence by Directly Targeting the CDK4/6-FOXM1 Axis in Ovarian Cancer, 2014-05-21

• The life cycle of polyploid giant cancer cell and dormancy in cancer: opportunities for novel therapeutic interventions, 2021-10-17

• Comprehensive epigenetic analysis of Notch pathway in high-grade serous ovarian cancer, 2012-11-28

• Induction of Antitumor Immunity in Mice by the Combination of Nanoparticle-Based Photothermolysis and Anti-PD-1 Checkpoint Inhibition, 2020-02-12

• Identifying and targeting angiogenesis-related microRNAs in ovarian cancer, 2019-07-09

• Fundamental Principles of Cancer Biology: Does it have relevance to the perioperative period?, 2015-07-08

• Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers, 2019-11-26

• Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers, 2018-10-08

• miR-34a Blocks Osteoporosis and Bone Metastasis by Inhibiting Osteoclastogenesis and Tgif2, 2014-06-25

• Role of CTGF in sensitivity to hyperthermia in ovarian and uterine cancers, 2016-11-01

• Ovarian Cancer Cell-derived Lysophosphatidic Acid Induces Glycolytic Shift and Cancer-associated Fibroblast-Phenotype in Normal and Peritumoral Fibroblasts, 2018-11-29

• Antagonism of Tumoral Prolactin Receptor Promotes Autophagy Related Cell Death, 2014-04-03

• Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics, 2022-10-14

• Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models, 2021-09-28

• MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer, 2014-11-06

• Epithelial-Mesenchymal Transition Polarization in Ovarian Carcinomas From Patients With High Social Isolation, 2020-07-21

• Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas, 2023-06-16

• New ways to successfully target tumor vasculature in ovarian cancer, 2015-07-31

• Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer, 2014-11-21

• Monocyte Subpopulations in Angiogenesis, 2014-02-20

• Platelets reduce anoikis and promote metastasis by activating YAP1 signaling, 2017-08-21

• MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer, 2021-08-11

• Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer, 2014-05-05

• Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP), 2017-10-23

• Erythropoietin Stimulates Tumor GrowthviaEphB4, 2015-10-17

• Chromosomal Instability in Tumor Initiation and Development, 2019-07-26

• Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype, 2021-02-09

• Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiers, 2015-09-28

• Chitosan Nanoparticles for miRNA Delivery, 2020-07-23

• FABP4 as a key determinant of metastatic potential of ovarian cancer, 2018-07-26

• Biological roles of the Delta family notch ligand Dll4 in tumor and endothelial cells in ovarian cancer, 2011-07-27

• Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex, 2022-10-17

• Immune microenvironment composition in high-grade serous ovarian cancers based onBRCAmutational status, 2021-09-02

• Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth, 2016-03-23

• Ionizing Radiation Induces Endothelial Inflammation and Apoptosis via p90RSK-Mediated ERK5 S496 Phosphorylation, 2018-03-14

• A Solution to the Dilution: The Role for Biomarkers in Advanced Ovarian Cancer, 2019-10-31

• CuS Nanodots with Ultrahigh Efficient Renal Clearance for Positron Emission Tomography Imaging and Image-Guided Photothermal Therapy, 2015-06-22

• Proceedings from the 9th International Conference on Ovarian Cancer, 2011-12-28

• Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells, 2013-03-20

• Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer, 2020-04-14

• Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs, 2017-02-20

• Integrated Analysis of Gene Expression and Tumor Nuclear Image Profiles Associated with Chemotherapy Response in Serous Ovarian Carcinoma, 2012-05-08

• Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma, 2022-08-30

• Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2, 2016-03-03

• Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage High-Grade Serous Ovarian Cancer, 2013-01-23

• The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial, 2021-01-07

• ADH1B promotes mesothelial clearance and ovarian cancer infiltration, 2018-05-18

• Therapeutic Targeting of PELP1 Prevents Ovarian Cancer Growth and Metastasis, 2011-03-18

• NRG1/ERBB3 pathway activation induces acquired resistance to XPO1 inhibitors, 2020-06-04

• Differential effects of EGFL6 on tumorversuswound angiogenesis, 2017-12-05

• Bisphosphonates Inhibit Stellate Cell Activity and Enhance Antitumor Effects of Nanoparticle Albumin Bound-Paclitaxel in Pancreatic Ductal Adenocarcinoma, 2014-09-05

• TARDBP regulates glycolysis in hepatocellular carcinoma by regulating PFKP through miR-520, 2013-05-15

• PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer, 2018-10-10

• Genomic DNA Copy-Number Alterations of thelet-7Family in Human Cancers, 2012-09-06

• Hypoxia Mediated Downregulation of miRNA Biogenesis Promotes Tumor Progression, 2014-10-29

• The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis, 2020-11-04

• Platelet "First Responders” in Wound Response, Cancer, and Metastasis, 2017-07-25

• Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer, 2021-04-16

• Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer, 2018-10-23

• Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer, 2021-10-15

• Predicting novel therapies and targets: regulation of Notch3 by the bromodomain protein BRD4, 2018-11-12

• Precision Nanomedicine Using Dual Positron Emission Tomography and Magnetic Resonance Temperature Imaging-Guided Photothermal Therapy, 2016-06-09

• Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression, 2016-01-04

• Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer, 2020-11-05

• Direct upregulation of STAT3 by microRNA-551b-3p deregulates growth and metastasis of ovarian cancer, 2016-05-05

• Stress, inflammation, and eicosanoids: an emerging perspective, 2018-10-27

• Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study, 2020-01-15

• Corrigendum: Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells, 2018-02-09

• CA-125 Level as a Prognostic Indicator in Type I and Type II Epithelial Ovarian Cancer, 2013-08-07

• Copper-64 Labeled PEGylated Exosomes for In Vivo Positron Emission Tomography and Enhanced Tumor Retention, 2019-09-27

• A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer, 2016-04-04

• Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer, 2015-06-03

• Platelet-derived growth factor receptor alpha (PDGFRa) targeting and relevant biomarkers in ovarian carcinoma, 2013-10-29

• XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A, 2015-04-15

• Copy Number Gain of hsa-miR-569 at 3q26.2 Leads to Loss of TP53INP1 and Aggressiveness of Epithelial Cancers, 2014-12-08

• Anesthetic Drugs and Cancer Progression: Fact or fiction, 2020-10-01

• Hypo Adenosine-to-Inosine miR-455-5p Editing Promotes Melanoma Growth and Metastasis, 2015-02-16

• THE PLATELET LIFELINE TO CANCER: CHALLENGES AND OPPORTUNITIES, 2018-04-12

• Pan-cancer clinical and molecular analysis of racial disparities, 2019-11-15

• Notch3 Pathway Alterations in Ovarian Cancer, 2014-04-17

• RNA Nanoparticles Harboring Annexin A2 Aptamer Can Target Ovarian Cancer for Tumor-Specific Doxorubicin Delivery, 2016-11-25

• MOLECULAR BIOMARKERS OF RESIDUAL DISEASE AFTER SURGICAL DEBULKING OF HIGH-GRADE SEROUS OVARIAN CANCER, 2014-04-22

• Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer, 2021-01-31

• Pelvic fractures and changes in bone mineral density following radiotherapy for cervical, endometrial and vaginal cancer: A prospective study of 239 women, 2020-03-03

• IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming, 2021-09-29

• Personalized cancer medicine-advances and socio-economic challenges, 2011-10-11

• Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer, 2023-02-15

• Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer, 2022-07-23

• Comprehensive Genomic Characterization of Long Non-Coding RNAs across Human Cancers, 2015-10-12

• RNA Interference-Based Therapy and Its Delivery Systems, 2018-01-03

• Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer, 2020-07-21

• Mucinous borderline ovarian tumorversusinvasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes, 2019-02-20

• Association between BRCA2 but not BRCA1 Mutations and Beneficial Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients with Ovarian Cancer, 2011-10-12

• MIIPhaploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer, 2016-11-24

• Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer, 2020-10-29

• Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer, 2012-04-06

• Targeting Src and tubulin in mucinous ovarian carcinoma, 2013-10-07

• Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non Small Cell Lung Cancer, 2013-10-24

• The ZNF304-integrin axis protects against anoikis, 2015-06-17

• Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer, 2018-06-23

• Convergence of Nanotechnology and Cancer Prevention: Are We There Yet?, 2014-07-24

• Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RASaxis in chemotherapy-resistant ovarian cancer, 2017-09-12

• Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity, 2021-04-29

• Targeting CCR2+macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer, 2022-01-30